IP Verse

Exendin For Treating Diabetes And Reducing Body Weight - EP2347762

PATENT ANALYSIS

Patent Details

Grant Date
May 8, 2019
Company
AMYLIN PHARMACEUTICALS, INC.
Oppositions

GENERICS (UK) LTD

INSTONE, TERRY/APPLEYARD LEES IP LLP/READ, HOWARD

More patents of Amylin Pharmaceuticals, Inc.

EP2341905

EP2347762

Want to monitor this patent?

Feel free to send us a message here and we will get back to you